Translational andrology and urology research, where is it heading?

Published: 2012-03-22

                    —Report of the 5th Greatwall Translational Andro-Urology Forum (GTAUF2012)

Zhong-Cheng Xin1, Ling-Yan Ji2

1Secretary General of GTAUF2012 and Professor & Vice Chairman of Andrology Center, Peking University First Hospital, Peking University; Beijing 100034, China

2Managing Editor, Translational Andrology and Urology, AME Publishing Company, Hong Kong

The 5th Great Wall Translational Andro-Urology Forum (GTAUF2012) in conjunction with the launch of the new journal Translational Andrology and Urology (TAU) was successfully held in Hainan International Conference and Exhibition Center, Haikou, China on March 8-12, 2012 (Figure 1). The forum was co-chaired by Prof. Ying-Lu Guo (Figure 2) and Prof. Tom F. Lue (Figure 3), both lifetime presidents of GTAUF and Editor-in-Chief of TAU and professor Zhi-Ming Bai (Figure 4), the president of local organizing committee of GTAUF2012.

Embracing the concept of the translational medicine, over 800 attendees from domestic and abroad gathered together to discuss how the scientific results of andrology and urology research can be translated into the clinical practice for better care of human health (Figure 5). More than 230 research papers were presented this forum and more than 100 lectures were delivered by 40 experts from America, Europe, Asia and 50 experts from China, lectures delivered by some of the editorial board members of TAU such as Dr Arthur Burnett (Figure 6) from The Johns Hopkins, Dr Run Wang (Figure 7) from University of Texas Medical School, Dr Gerald Brock (Figure 8) from University of Western Ontario are listed in table 1. In addition to Plenary Sessions, China-Japan-Korea (G3) Andrology-Urologist Symposium and the 3rd Cross-Strait Andro-Urologist Symposium were specially organized to strengthen regional scientific exchanges and cooperation. Live surgery & Video presentation at Haikou City Hospital on March 11th was informative, vivid and dynamic and were warmly welcomed by attendees.

The three-day meeting was completed in the warm applause of scientists and clinical doctors. For more information, please visit Proceeding is available at

We look forward to a more exciting and successful forum, the 6th Great Wall Translational Andro-Urology Forum(GTAUF2014) and Asia Pacific Society for the Study of Aging Male (APSSAM2014), which will be held in autumn of 2014 in Beijing.


Table 1. Lectures at GTAUF2012 by some of the editorial board members of TAU.

  Speaker Lecture Link
1 Arthur Burnett (USA) Testosterone therapy in Hypogonadal man with sickle cell disease
2 Arthur Burnett(USA) Testosterone replacement after prostate cancer treatment
3 Ching Shwun LIN(USA) Stem cell for urinary incontinence
4 Ching-Shwun Lin(USA)
PDE5, the key enzyme for erectile function

David Ralph(USA)

(Figure 9)
Phalloplasty for the genetic male
6 Gerald Brock (Canada) Post prostatectomy erectile optimization
7 Gerald Brock(USA) PDE5i's are they too important a drug class to be used only for erectile dysfunction?
8 Hong LI(Chengdu) Male sexual function before and after urethral stricture surgery
9 Jae-Seung PAICK(Korea) Ejaculatory disorder in Medical and surgical Therapy of BPH
10 Jun Kyu SUH(Korea) Cavernous angiogenesis as a novel therapeutic strategy for erectile dysfunction

Leland Wei-Kuo Chung (USA)

(Figure 10)
Osteomimicry in Prostate Stromal-Epithelial Interaction: From Biology to Therapy

Li Qun ZHOU(Beijing)

(Figure 11)
Laparascopic surgery on Urology in China; Present and future
13 Li Qun ZHOU(Beijing) Retroperitoneal laparoendoscopic single-site radical nephrectomy using self-made single-port device: Initial experience

Michael Coburn(USA)

(Figure 12)
Male Genital Trauma and Reconstructive Surgery - The Houston Experience".
18 Nam Cheol PARK(Korea) Current Management of Hemospermia

Nian Zeng XING(Beijing)

(Figure 13)
Laparoscopic Nephron-Sparing Surgery with Selective Clamping of Renal Arterial Branches Using Laparoscopic Ultrasonography
20 Run WANG(USA) Androgen Deprivation therapy for prostate cancer and the impact on male sexual function
21 Sae Woong KIM(Korea) Phytotherapy : Emerging Therapeutic Option in Urologic Disease
22 Sang Wen HAN (Korea) Vesicoureteral reflux and bladder dysfunction

Shu Jie XIA(Shanghai)

(Figure 14)
The Exploitation and application of the new laser technology in minimally invasive urologic surgery
24 Tom F Lue (USA) New concept and algorithm for priapism
25 Tom F Lue(USA) The challenges of Peyronie's disease
26 Tom F Lue(USA) Urethra spinctor for incontinance
27 Xin GAO(Guangzhou) Nerve-sparing laparoscopic radical prostatectomy (100 cases report)
28 Yong YANG(Beiing) Painful bladder syndrome/interstitial cystitis

Zhi Jie CHANG(Beijing)

(Figure 15)
A Novel Gene Regulates Tumorigenesis at the Transcriptional Level

Zhong Cheng XIN(Beijing)

(Figure 16)
Al-Ghorab Shunt plus Intracavernous Tunneling for Prolonged Ischemic Priapism
31 Zhong Cheng XIN(Beijing) Combined oral therapy with sildenafil and doxazosin GITS for treating Chinese patients of ED with LUTS/BPH
32 Zhong Cheng XIN(Beijing) Urethra fibrous-muscular pathological changes in SUI rat model and the effect of periurethral injection ADSCl
33 Zhong Cheng XIN(Beijing) Experience of AMS penile prosthesis implantation for treating Chinese patients with severe erectile dysfunction
34 Zhong Cheng XIN(Beijing) Three piece penile prosthesis implantation for sever ED  


Figure 1. Opening ceremony of the forum

Figure 2. Ying-Lu Guo, MD. Institute of Urology, Peking University, Beijing, China.

Figure 3. Tom F. Lue, MD, ScD (Hon), FACS. Department of Urology, University of California, San Francisco, San Francisco, USA.

Figure 4. Zhi-Ming Bai, MD. Department of Urology, Haikou Municipal Hospital, Haikou, China

Figure 5. Attendees from more than 30 countries

Figure 6. Arthur Burnett,MD. Johns Hopkins Medical Institutions,Baltimore, Maryland, USA.

Figure 7. Run Wang, MD, FACS. University of Texas Medical School at Houston and MD Anderson Cancer Center, Houston, TX, USA.

Figure 8. Gerald Brock, MD, FRCSC. Professor of Surgery Division of Urology University of Western Ontario, Canada.

Figure 9. David Ralph, MD, BSc, MS, FRCS . Institute of Urology, University College, London, UK.

Figure 10. Leland W. K. Chung, MD. Uro-Oncology Research, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Figure 11. Li Qun Zhou, MD. Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, Beijing, China.

Figure 12. Michael Coburn, MD.Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA.

Figure 13. Nianzeng Xing, MD. Department of Urology, Affiliated Beijing Chaoyang Hospital of Capital Medical University, Beijing, China.

Figure 14. Shu Jie Xia, MD. Department of Urology, Shanghai First People’s Hospital, Shanghai Jiao Tong University, Shanghai, China.

Figure 15. Zhi Jie Chang, PhD. Department of Biological Sciences and Biotechnology, School of Medicine, Tsinghua University, China.

Figure 16. Zhong-Cheng Xin, MD. Andrology Center and the Department of Urology, Peking University First Hospital, Beijing , China.